Skip to main content

Advertisement

Log in

Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis), or systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Hearing loss in patients with autoimmune diseases, such as systemic lupus erythematosus (SLE), granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis), or rheumatoid arthritis (RA), is controversial. Many studies lack measurements of bone-conduction thresholds to sufficiently differentiate between sensorineural hearing loss and conductive hearing loss. In addition, many studies lack control groups or comparisons to an age-related normal hearing threshold. This study investigates hearing performance with an extended audiological battery using psychoacoustic and objective measures. A total of 22 adults with RA, 16 with GPA, 20 with SLE, and two age- and gender-matched control groups (n = 34 for GPA and RA and n = 42 for SLE) were included. Pure-tone hearing thresholds, speech perception in quiet and noise, tympanometry, and high-resolution otoacoustic emissions were assessed. GPA patients exhibited impaired pure-tone hearing compared to the control group, whereas SLE and RA patients did not. In GPA patients, a larger air-bone gap indicated conductive hearing loss. In addition, speech perception was reduced exclusively in GPA patients. A significant correlation was found between hearing loss and both the cumulative steroid dose and number of organ manifestations in GPA and SLE patients. Our data indicate that GPA and SLE patients are at moderate-to-high risk of conductive hearing loss. In contrast, RA patients are at low risk of disease-associated hearing loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lobo FS, Dossi MO, Batista L et al (2016) Hearing impairment in patients with rheumatoid arthritis: association with anti-citrullinated protein antibodies. Clin Rheumatol 35(9):2327–2332. doi:10.1007/s10067-016-3278-x

    Article  PubMed  Google Scholar 

  2. Emamifar A, Bjoerndal K, Hansen IMJ (2016) Is hearing impairment associated with rheumatoid arthritis? A review. Open Rheumatol J 10:26–32. doi:10.2174/1874312901610010026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Emamifar A, Bjoerndal K, Hansen IMJ (2016) Rheumatoid arthritis and hearing impairment: a review. Scand J Rheumatol 45:18

    Google Scholar 

  4. Colletti V, Fiorino FG, Bruni L et al (1997) Middle ear mechanics in subjects with rheumatoid arthritis. Audiology 36(3):136–146

    Article  CAS  PubMed  Google Scholar 

  5. Halligan CS, Bauch CD, Brey RH et al (2006) Hearing loss in rheumatoid arthritis. Laryngoscope 116(11):2044–2049. doi:10.1097/01.mlg.0000241365.54017.32

    Article  PubMed  Google Scholar 

  6. Dikici O, Muluk NB, Tosun AK et al (2009) Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels. Eur Arch Otorhinolaryngol 266(11):1719–1726. doi:10.1007/s00405-009-0975-y

    Article  PubMed  Google Scholar 

  7. Takatsu M, Higaki T, Kinoshita H et al (2005) Ear involvement in patients with rheumatoid arthritis. Otol. Neurotol. 26(4):755–761

    Article  PubMed  Google Scholar 

  8. Callejo FJG, Noelia Muñoz Fernández NM, Vernetta CP et al (2007) Hearing impairment in patients with rheumatoid arthritis. Acta Otorrinolaringol Esp 58(6):232–238

    Article  Google Scholar 

  9. Pascual-Ramos V, Contreras-Yáñez I, Enríquez L et al (2012) Hearing impairment in a tertiary-care-level population of Mexican rheumatoid arthritis patients. J Clin Rheumatol 18(8):393–398. doi:10.1097/RHU.0b013e31827732d3

    Article  PubMed  Google Scholar 

  10. La Lasso de Vega M, Villarreal IM, Lopez-Moya J et al (2016) Examination of hearing in a rheumatoid arthritis population: role of extended-high-frequency audiometry in the diagnosis of subclinical involvement. Scientifica (Cairo) 2016:5713283. doi:10.1155/2016/5713283

    Google Scholar 

  11. Ozcan M, Karakus MF, Gunduz OH et al (2002) Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int 22(1):16–19. doi:10.1007/s00296-002-0185-z

    Article  PubMed  Google Scholar 

  12. Luis Trevino-Gonzalez J, Jesus Villegas-Gonzalez M, Enrique Munoz-Maldonado G et al (2015) Subclinical sensorineural hearing loss in female patients with rheumatoid arthritis. CIRUGIA Y CIRUJANOS 83(5):364–370. doi:10.1016/j.circir.2015.05.026

    Article  Google Scholar 

  13. Salvinelli F, Cancilleri F, Casale M et al (2004) Hearing thresholds in patients affected by rheumatoid arthritis. Clin Otolaryngol Allied Sci 29(1):75–79

    Article  CAS  PubMed  Google Scholar 

  14. Martinez del Pero M, Rasmussen N, Chaudhry A et al. (2013) Structured clinical assessment of the ear, nose and throat in patients with granulomatosis with polyangiitis (Wegener’s). Eur Arch Otorhinolaryngol: 345–354

  15. Nakamaru Y, Takagi D, Suzuki M et al (2016) Otologic and rhinologic manifestations of eosinophilic granulomatosis with polyangiitis. Audiol Neuro Otol 21(1):45–53. doi:10.1159/000442040

    Article  Google Scholar 

  16. Seccia V, Fortunato S, Cristofani-Mencacci L et al (2016) Focus on audiologic impairment in eosinophilic granulomatosis with polyangiitis. Laryngoscope 126(12):2792–2797. doi:10.1002/lary.25964

    Article  CAS  PubMed  Google Scholar 

  17. Takagi D, Nakamaru Y, Maguchi S et al (2002) Otologic manifestations of Wegener’s granulomatosis. Laryngoscope 112(9):1684–1690. doi:10.1097/00005537-200209000-00029

    Article  PubMed  Google Scholar 

  18. Morales-Angulo C, García-Zornoza R, Obeso-Agüera S et al (2012) Manifestaciones otorrinolaringológicas en pacientes con granulomatosis de Wegener (granulomatosis con poliangeitis) (Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis)). Acta Otorrinolaringol Esp 63(3):206–211. doi:10.1016/j.otorri.2011.12.002

    Article  PubMed  Google Scholar 

  19. Bakthavachalam S, Driver MS, Cox C et al (2004) Hearing loss in Wegener’s granulomatosis. Otol Neurotol 25(5):833–837

    Article  PubMed  Google Scholar 

  20. Yoshida N, Iino Y (2014) Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int 63:523–532

    Article  CAS  PubMed  Google Scholar 

  21. Caldarelli DD, Rejowski JE, Corey JP (1986) Sensorineural hearing loss in lupus erythematosus. Am J Otol 7(3):210–213

    CAS  PubMed  Google Scholar 

  22. Sone M, Schachern PA, Paparella MM et al (1999) Study of systemic lupus erythematosus in temporal bones. Ann Otol Rhinol Laryngol 108(4):338–344

    Article  CAS  PubMed  Google Scholar 

  23. Bouman H, Klis SF, de Groot JC et al (1998) Induction of endolymphatic hydrops in the guinea pig by perisaccular deposition of sepharose beads carrying and not carrying immune complexes. Hear Res 117(1–2):119–130

    Article  CAS  PubMed  Google Scholar 

  24. Khalidi NA, Rebello R, Robertson DD (2008) Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review. J Laryngol Otol 122(12):1371–1376. doi:10.1017/S0022215108001783

    Article  CAS  PubMed  Google Scholar 

  25. Narula AA, Powell RJ, Davis A (1989) Frequency-resolving ability in systemic lupus erythematosus. Br J Audiol 23(1):69–72

    Article  CAS  PubMed  Google Scholar 

  26. Karabulut H, Dagli M, Ates A et al (2010) Results for audiology and distortion product and transient evoked otoacoustic emissions in patients with systemic lupus erythematosus. J Laryngol Otol 124(2):137–140. doi:10.1017/S0022215109991332

    Article  CAS  PubMed  Google Scholar 

  27. Maciaszczyk K, Durko T, Waszczykowska E et al (2011) Auditory function in patients with systemic lupus erythematosus. Auris Nasus Larynx 38(1):26–32. doi:10.1016/j.anl.2010.04.008

    Article  PubMed  Google Scholar 

  28. Abbasi M, Yazdi Z, Kazemifar AM et al (2013) Hearing loss in patients with systemic lupus erythematosus. Glob J Health Sci 5(5):102–106. doi:10.5539/gjhs.v5n5p102

    Article  PubMed  PubMed Central  Google Scholar 

  29. Batuecas-Caletrío A, del Pino-Montes J, Cordero-Civantos C et al (2013) Hearing and vestibular disorders in patients with systemic lupus erythematosus. Lupus 22(5):437–442. doi:10.1177/0961203313477223

    Article  PubMed  Google Scholar 

  30. Lin C, Lin S-W, Weng S-F et al (2013) Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study. Audiol Neurootol 18(2):95–100. doi:10.1159/000345512

    Article  PubMed  Google Scholar 

  31. Jerger J (1970) Clinical experience with impedance audiometry. Arch Otolaryngol Head Neck Surg 92(4):311–324

    Article  CAS  Google Scholar 

  32. Boege P, Janssen T (2002) Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears. J Acoust Soc Am 111(4):1810–1818. doi:10.1121/1.1460923

    Article  PubMed  Google Scholar 

  33. Lin C-F, Lee K-J, Yu S-S et al (2016) Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss. Laryngoscope 126(1):142–149. doi:10.1002/lary.25333

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Jan-Leif Sommermeyer (Halle/Saale) for patient recruitment and data recording. We thank Manfred Mauermann (Oldenburg) for providing the hardware for DPOAE and fine structure hearing threshold measurements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Torsten Rahne.

Ethics declarations

All patients provided written informed consent. The study was approved by the local ethics committee.

Funding

This work was supported by intramural funding. No third party funding was provided.

Disclosures

None.

Additional information

Key messages

• We found neither conductive hearing loss nor mixed hearing loss in RA patients.

• We found a high conductive hearing loss and mixed hearing loss prevalence in the GPA group.

• The prevalence of sensorineural hearing loss was higher in SLE patients than in the control group.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahne, T., Clauß, F., Plontke, S.K. et al. Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis), or systemic lupus erythematosus. Clin Rheumatol 36, 1501–1510 (2017). https://doi.org/10.1007/s10067-017-3651-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3651-4

Keywords

Navigation